Tremeau Pharmaceuticals, Inc. Employee Directory
Pharmaceutical ManufacturingMassachusetts, United States0-1 Employees
Tremeau Pharmaceuticals, Inc. is a Massachusetts-based pharmaceutical company focused on developing non-opioid treatments for acute and chronic pain in well-defined patient populations with significant unmet needs. Its approach centers on COX-2 selective NSAIDs and aims to offer clinically differentiated pain therapies, particularly for conditions where pain management is limited by current options. The company targets patients with rare or specific pain indications and seeks to address serious pain challenges without relying on opioids. Based in Concord, Massachusetts, Tremeau positions itself within the pharmaceutical manufacturing sector, pursuing development of a deuterium-enriched etoricoxib compound known as TRM-362 for acute pain, reflecting its research-driven strategy in non-opioid analgesia. Since its early foundation, the firm has engaged in leadership appointments and has publicly disclosed its focus on developing generic and novel non-opioid pain treatments for defined patient groups.